Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients

OBJECTIVES: The objectives of the study are to explore tolerability, acceptability and oncological outcomes for patients with high‐risk non‐muscle‐invasive bladder cancer (NMIBC) treated with hyperthermic intravesical chemotherapy (HIVEC) and mitomycin‐C (MMC) at our institution. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Conroy, Samantha, Pang, Karl, Jubber, Ibrahim, Hussain, Syed A., Rosario, Derek J., Cumberbatch, Marcus G., Catto, James W. F., Noon, Aidan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071075/
https://www.ncbi.nlm.nih.gov/pubmed/37025474
http://dx.doi.org/10.1002/bco2.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071075/
https://www.ncbi.nlm.nih.gov/pubmed/37025474
http://dx.doi.org/10.1002/bco2.203

Ejemplares similares